Want to track RNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avidity Biosciences Inc. (RNA) Statistics
Valuation metrics
Market Cap 196.03M
Enterprise value -71.02M
Trailing P/E (ttm) -4.25
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) 9.47
Price/Book (mrq) 0.83
Enterprise Value/Revenue -3.47
Enterprise Value/EBITDA 1.1
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 108.1K
Average volume (90 days) 192.71K
Price summary
52-Week low 11.13
52-Week high 73.06
Beta -
50-Day moving average 12.55
200-Day moving average 29.62
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.16%
Operating margin -3.19%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 13.04%
Book value per share (mrq) 13.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
